Immune and cancer testis antigen landscape in sarcoma
by Christina Black | Nov 19, 2021
Cancer testis antigen burden: A novel predictive biomarker for immunotherapy in solid tumors
by Christina Black | Nov 10, 2021
Cancer/testis antigen expression landscape in gastroesophageal adenocarcinoma
by Christina Black | Sep 17, 2021
Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response
by Christina Black | Jul 19, 2021
Follow Us on Twitter
LABCORP EXPANDS ACCESS TO COMPREHENSIVE GENOMIC TESTING THROUGH NEW LUNG CANCER PROGRAM UTILIZING OmniSeq INSIGHT
https://tinyurl.com/59xf82c6
@OmniSeq
@Labcorp
#oncology
#precisionmedicine
Last year, the Buffalo-based cancer diagnostics firm @OmniSeq quietly was acquired by one of the world's largest life science companies, @Labcorp . Developing molecular diagnostic tests for cancer patients, OmniSeq is looking to scale its operations.
https://tinyurl.com/muxryphz